Smoking and Methotrexate Inefficacy in Rheumatoid Arthritis: What About Underlying Molecular Mechanisms?

J Rheumatol. 2021 Oct;48(10):1495-1497. doi: 10.3899/jrheum.210217. Epub 2021 Jun 15.

Authors

Gerrit Jansen¹, Maurits C F J de Rotte², Robert de Jonge²

Affiliations

¹ G. Jansen, PhD, Biochemist, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Center, location VUmc; g.jansen@amsterdamumc.nl.
² M.C. de Rotte, PhD, Clinical Chemist, R. de Jonge, PhD, Professor of Clinical Chemistry, Department of Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, the Netherlands.

PMID: 34329189
DOI: 10.3899/jrheum.210217

No abstract available

Publication types

Editorial
Comment

MeSH terms

Arthritis, Rheumatoid* / drug therapy
Humans
Methotrexate* / adverse effects
Smoking / adverse effects

Substances

Methotrexate